DEFA

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant   x                             Filed by a party other than the Registrant  ¨

Check the appropriate box:

 

¨ Preliminary Proxy Statement

 

¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

¨ Definitive Proxy Statement

 

x Definitive Additional Materials

 

¨ Soliciting Material Pursuant to §240.14a-12

AVEO PHARMACEUTICALS, INC.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)

Payment of Filing Fee (Check the appropriate box):

 

x No fee required.

 

¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  (1) Title of each class of securities to which transaction applies:

 

 

 

  (2) Aggregate number of securities to which transaction applies:

 

 

 

  (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

  (4) Proposed maximum aggregate value of transaction:

 

 

 

  (5) Total fee paid:

 

 

 

¨ Fee paid previously with preliminary materials:

 

¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.


  (1) Amount Previously Paid:

 

 

 

  (2) Form, Schedule or Registration Statement No.:

 

 

 

  (3) Filing Party:

 

 

 

  (4) Date Filed:

 

 

 

¨ Preliminary Proxy Statement

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on May 28, 2015

 

                       
          

 

Meeting Information            

 

   
           Meeting Type:   Annual Meeting    

        AVEO PHARMACEUTICALS INC

        For holders as of:   April 02, 2015    
          

 

Date:  May 28, 2015

 

 

      Time: 10:00 AM EDT

      
          

 

Location:    the offices of

   
          

 Wilmer Cutler Pickering Hale

 and Dorr LLP,

   
       

 60 State Street,

 Boston, Massachusetts 02109

 

   
            

 

   AVEO PHARMACEUTICALS INC.

  650 EAST KENDALL STREET

  CAMBRIDGE, MA 02142

   

 

You are receiving this communication because you hold shares in the above named company.

   

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

   

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

   

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

0000244819_1     R1.0.0.51160


—  Before You Vote  —

How to Access the Proxy Materials

 

 

 

Proxy Materials Available to VIEW or RECEIVE:

   
   

 

1. Notice & Proxy Statement      2. Form 10-K

 

How to View Online:

Have the information that is printed in the box marked by the arrow  LOGO  (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

 

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

                                 1) BY INTERNET:          www.proxyvote.com

                                 2) BY TELEPHONE:      1-800-579-1639

                                 3) BY E-MAIL*:              sendmaterial@proxyvote.com

 

  *    If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the   arrow  LOGO  (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 14, 2015 to facilitate timely delivery.

 

   
       

 

—  How To Vote  —

Please Choose One of the Following Voting Methods

 

 

          
   

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow  LOGO  available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

 

    
        

0000244819_2    R1.0.0.51160


Voting items   

The Board of Directors recommends you vote

FOR the following:

  

 

1.    Election of Directors
   Nominees
01    Michael Bailey    02    Kenneth M. Bate    03    Anthony B. Evnin    04    Tuan Ha-Ngoc    05    Raju Kucherlapati
06    Henri A. Termeer    07    Robert C. Young                  

The Board of Directors recommends you vote FOR proposals 2, 3 and 4:

 

2. To approve an amendment to the Restated Certificate of Incorporation

 

3. To approve an advisory vote on executive compensation

 

4 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2015

NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof.

0000244819_3    R1.0.0.51160


 

 

 

 

0000244819_4    R1.0.0.51160